<unk>  is a glycosaminoglycan (GAG)-specific enzyme that is FDA approved for the treatment of Mucopolysaccharidosis VI.   Common adverse reactions include rash, pain, urticaria, pyrexia, pruritus, chills, headache, nausea, vomiting, abdominal pain and dyspnea, infusion-related reactions.
Galsulfase
Idursulfase
Elosulfase alfa
Levoleucovorin
Gadoteric acid
Epoetin alfa
Oxydisulfoton
Rasburicase